Covid-19.
Conditions
Interventions
Intervention 1: Intervention group: Includes 20 patients with COVID-19 who, in addition to their usual treatments, will take 3 1000 mg omega-3 capsules daily for 2 weeks (14 days). Intervention 2: Con
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Being 20 to 65 years old Detection of COVID-19 based on PCR test Willingness to participate in the study Covid 19 patients without underlying disease (in consultation with the consultant)
Exclusion criteria
Exclusion criteria: Breastfeeding and pregnancy Advanced respiratory distress syndrome leading to intubation Patients with coagulation disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of interleukin-6. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum levels of blood cells. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum levels of reactive protein-C. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum levels of erythrocyte sedimentation rate. Timepoint: Beginning and end of the study. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKeianoush Karami
Tehran University of Medical Sciences
Outcome results
None listed